ICUI

SEC source: 0001410442-20-000011 · edgardoc.xml · nonDerivative · entry 4

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,241

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020.

SEC source: 0001410442-20-000011 · edgardoc.xml · nonDerivative · entry 3

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,441

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020.

SEC source: 0001410442-20-000011 · edgardoc.xml · derivative · entry 5

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 434,066

Underlying: Common Stock · 2,300 shares

Expires 2024-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020.

F4 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the vesting commencement date of February 13, 2014. Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of the exercise price for 30 consecutive trading days.

SEC source: 0001410442-20-000011 · edgardoc.xml · nonDerivative · entry 2

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,241

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020.

F3 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001410442-20-000011 · edgardoc.xml · nonDerivative · entry 1

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,541

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020.

SEC source: 0001073397-20-000005 · edgardoc.xml · derivative · entry 17

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,295

Underlying: Common Stock · 17,000 shares

Expires 2022-02-01

F11 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.

SEC source: 0001073397-20-000005 · edgardoc.xml · nonDerivative · entry 13

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 240,314

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.72 to $196.24, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-20-000005 · edgardoc.xml · nonDerivative · entry 12

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 242,839

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.56 to $195.23, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-20-000005 · edgardoc.xml · nonDerivative · entry 11

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 251,278

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.54 to $194.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-20-000005 · edgardoc.xml · nonDerivative · entry 10

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 257,314

SEC source: 0001073397-20-000005 · edgardoc.xml · derivative · entry 16

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,295

Underlying: Common Stock · 15,066 shares

Expires 2022-02-01

F11 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.

SEC source: 0001073397-20-000005 · edgardoc.xml · derivative · entry 15

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,361

Underlying: Common Stock · 7,934 shares

Expires 2022-02-01

F11 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.

SEC source: 0001073397-20-000005 · edgardoc.xml · nonDerivative · entry 9

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 240,314

F7 · price: he price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.50 to $195.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-20-000005 · edgardoc.xml · nonDerivative · entry 8

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 247,814

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.50 to $194.15, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-20-000005 · edgardoc.xml · nonDerivative · entry 7

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255,380

F5 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001073397-20-000005 · edgardoc.xml · nonDerivative · entry 6

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255,382

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.00 to $196.78, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-20-000005 · edgardoc.xml · nonDerivative · entry 5

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255,640

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.00 to $194.29, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-20-000005 · edgardoc.xml · nonDerivative · entry 4

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,518

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.97 to $193.48, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-20-000005 · edgardoc.xml · nonDerivative · entry 3

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 261,619

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.94 to $192.76, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-20-000005 · edgardoc.xml · nonDerivative · entry 2

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 263,314

SEC source: 0001073397-20-000005 · edgardoc.xml · nonDerivative · entry 1

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 248,248

SEC source: 0001410442-20-000010 · edgardoc.xml · derivative · entry 3

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 436,366

Underlying: Common Stock · 11,500 shares

Expires 2024-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020.

F4 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the vesting commencement date of February 13, 2014. Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of the exercise price for 30 consecutive trading days.

SEC source: 0001410442-20-000010 · edgardoc.xml · nonDerivative · entry 2

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,241

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020.

F3 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001410442-20-000010 · edgardoc.xml · nonDerivative · entry 1

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,741

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020.

SEC source: 0001410442-21-000004 · edgardoc.xml · derivative · entry 4

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 66,000

Underlying: Common Stock · 66,000 shares

Expires 2024-02-24

F1 · ownership.nature: This transaction represented a gift of securities from the reporting person to two trusts for the benefit of family members, who share the same household. The reporting person disclaims beneficial ownership of the shares held by the trusts, and this report shall not be deemed as an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose.

SEC source: 0001410442-21-000004 · edgardoc.xml · derivative · entry 3

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 381,866

Underlying: Common Stock · 66,000 shares

Expires 2024-02-24

F1 · kind: This transaction represented a gift of securities from the reporting person to two trusts for the benefit of family members, who share the same household. The reporting person disclaims beneficial ownership of the shares held by the trusts, and this report shall not be deemed as an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose.

SEC source: 0001073398-20-000006 · edgardoc.xml · derivative · entry 4

SWINNEY ROBERT S · CIK 0001073398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,500 shares

Expires 2020-10-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These stock options vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

SEC source: 0001073398-20-000006 · edgardoc.xml · nonDerivative · entry 2

SWINNEY ROBERT S · CIK 0001073398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,505

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2019.

F2 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001073398-20-000006 · edgardoc.xml · nonDerivative · entry 1

SWINNEY ROBERT S · CIK 0001073398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,782

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001410442-20-000008 · edgardoc.xml · derivative · entry 3

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 447,866

Underlying: Common Stock · 11,500 shares

Expires 2024-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020.

F4 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the vesting commencement date of February 13, 2014. Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of the exercise price for 30 consecutive trading days.

SEC source: 0001410442-20-000008 · edgardoc.xml · nonDerivative · entry 2

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,241

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020.

F3 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001410442-20-000008 · edgardoc.xml · nonDerivative · entry 1

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,741

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020.

SEC source: 0001410442-21-000004 · edgardoc.xml · nonDerivative · entry 2

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 60,000

F1 · ownership.nature: This transaction represented a gift of securities from the reporting person to two trusts for the benefit of family members, who share the same household. The reporting person disclaims beneficial ownership of the shares held by the trusts, and this report shall not be deemed as an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose.

SEC source: 0001410442-21-000004 · edgardoc.xml · nonDerivative · entry 1

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,241

F1 · kind: This transaction represented a gift of securities from the reporting person to two trusts for the benefit of family members, who share the same household. The reporting person disclaims beneficial ownership of the shares held by the trusts, and this report shall not be deemed as an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose.

SEC source: 0001615192-20-000004 · edgardoc.xml · derivative · entry 3

McGrody Kevin J · CIK 0001615192 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 572 shares

Expires 2020-09-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

SEC source: 0001615192-20-000004 · edgardoc.xml · nonDerivative · entry 2

McGrody Kevin J · CIK 0001615192 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,331

SEC source: 0001615192-20-000004 · edgardoc.xml · nonDerivative · entry 1

McGrody Kevin J · CIK 0001615192 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,632

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001410442-20-000007 · edgardoc.xml · derivative · entry 6

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 459,366

Underlying: Common Stock · 11,500 shares

Expires 2024-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020.

F7 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the vesting commencement date of February 13, 2014. Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of the exercise price for 30 consecutive trading days.

SEC source: 0001410442-20-000007 · edgardoc.xml · nonDerivative · entry 5

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,181

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.68 to $200.04, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001410442-20-000007 · edgardoc.xml · nonDerivative · entry 4

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,839

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020.

F5 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001410442-20-000007 · edgardoc.xml · nonDerivative · entry 3

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,339

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.49 to $198.35, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001410442-20-000007 · edgardoc.xml · nonDerivative · entry 2

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,225

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.44 to $197.37, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001410442-20-000007 · edgardoc.xml · nonDerivative · entry 1

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,681

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020.

SEC source: 0001410442-20-000006 · edgardoc.xml · derivative · entry 3

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 470,866

Underlying: Common Stock · 11,500 shares

Expires 2024-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020.

F4 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the vesting commencement date of February 13, 2014. Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of the exercise price for 30 consecutive trading days.

SEC source: 0001410442-20-000006 · edgardoc.xml · nonDerivative · entry 2

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,181

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020.

F3 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001410442-20-000006 · edgardoc.xml · nonDerivative · entry 1

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,681

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020.

SEC source: 0001804831-20-000004 · edgardoc.xml · derivative · entry 3

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,208

Underlying: Common Stock · 1,208 shares

Expires 2021-08-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

SEC source: 0001804831-20-000004 · edgardoc.xml · nonDerivative · entry 2

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 917

SEC source: 0001804831-20-000004 · edgardoc.xml · nonDerivative · entry 1

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,553

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

SEC source: 0001073397-20-000004 · edgardoc.xml · nonDerivative · entry 1

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 240,314

F1 · price: This was a bona fide gift with no payment in consideration